Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154

Proceedings of the National Academy of Sciences of the United States of America

Volumn 96, Issue 14, 1999, Pages 8132-8137

  Kenyon, N S ^a   Chatzipetrou, M ^a   Masetti, M ^a   Ranuncoli, A ^a   Oliveira, M ^a   Wagner, J L ^a   Kirk, A D ^a   Harlan, D M ^a   Burkly, L C ^a   Ricordi, C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MONOCLONAL ANTIBODY; MONOCLONAL ANTOBODY CD 154; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; DRUG EFFECT; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; INSULIN RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE REACTION; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; PRIORITY JOURNAL; RHESUS MONKEY; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES; BLOOD GLUCOSE; C-PEPTIDE; CD40 LIGAND; DIABETES MELLITUS, TYPE 1; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; LIVER; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; PANCREATECTOMY; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033529235     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.96.14.8132     Document Type: Article

References (52)